2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide

C54H78N8O8 — CID 170074390

IUPAC2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide
SMILESCCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)N1CCO[C@@H](C[C@H](NC(=O)C(COC3CCN(C(=O)C#CC(C)(C)N(C)C)CC3)C(C)C)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1
InChIInChI=1S/C54H78N8O8/c1-12-61-46-18-17-37-29-41(46)42(49(61)40-15-13-23-55-48(40)36(4)67-11)31-53(5,6)34-70-52(66)44-16-14-24-62(57-44)51(65)45(30-39-32-60(37)27-28-68-39)56-50(64)43(35(2)3)33-69-38-20-25-59(26-21-38)47(63)19-22-54(7,8)58(9)10/h13,15,17-18,23,29,35-36,38-39,43-45,57H,12,14,16,20-21,24-28,30-34H2,1-11H3,(H,56,64)/t36-,39-,43?,44-,45-/m0/s1
InChIKeyJTESRHWHAFYFGF-SIFQVGNESA-N
MW967.27 g/mol
LogP5.76
Rot. Bonds11

About 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide

2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide (PubChem CID 170074390) has the molecular formula C54H78N8O8 and a molecular weight of 967.27 g/mol. Its IUPAC name is 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide.

Molecular Properties

Compound Name2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide
PubChem CID170074390
Molecular FormulaC54H78N8O8
Molecular Weight967.27 g/mol
Exact Mass966.59
IUPAC Name2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide
SMILESCCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)N1CCO[C@@H](C[C@H](NC(=O)C(COC3CCN(C(=O)C#CC(C)(C)N(C)C)CC3)C(C)C)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1
InChIInChI=1S/C54H78N8O8/c1-12-61-46-18-17-37-29-41(46)42(49(61)40-15-13-23-55-48(40)36(4)67-11)31-53(5,6)34-70-52(66)44-16-14-24-62(57-44)51(65)45(30-39-32-60(37)27-28-68-39)56-50(64)43(35(2)3)33-69-38-20-25-59(26-21-38)47(63)19-22-54(7,8)58(9)10/h13,15,17-18,23,29,35-36,38-39,43-45,57H,12,14,16,20-21,24-28,30-34H2,1-11H3,(H,56,64)/t36-,39-,43?,44-,45-/m0/s1
InChIKeyJTESRHWHAFYFGF-SIFQVGNESA-N
XLogP5.76
TPSA160.04 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds11
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500967.27
LogP ≤ 55.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide?
The IUPAC name of 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide (CID 170074390) is 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide.
What is the SMILES notation for 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide?
The canonical SMILES for 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide is CCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)N1CCO[C@@H](C[C@H](NC(=O)C(COC3CCN(C(=O)C#CC(C)(C)N(C)C)CC3)C(C)C)C(=O)N3CCC[C@H](N3)C(=O)OCC(C)(C)C2)C1.
What is the InChIKey of 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide?
The InChIKey is JTESRHWHAFYFGF-SIFQVGNESA-N. The full InChI is InChI=1S/C54H78N8O8/c1-12-61-46-18-17-37-29-41(46)42(49(61)40-15-13-23-55-48(40)36(4)67-11)31-53(5,6)34-70-52(66)44-16-14-24-62(57-44)51(65)45(30-39-32-60(37)27-28-68-39)56-50(64)43(35(2)3)33-69-38-20-25-59(26-21-38)47(63)19-22-54(7,8)58(9)10/h13,15,17-18,23,29,35-36,38-39,43-45,57H,12,14,16,20-21,24-28,30-34H2,1-11H3,(H,56,64)/t36-,39-,43?,44-,45-/m0/s1.
What are the key properties of 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide?
2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide has a molecular weight of 967.27 g/mol, XLogP of 5.76, 11 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]piperidin-4-yl]oxymethyl]-N-[(6S,8S,14S)-22-ethyl-21-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]-3-methylbutanamide is sourced from PubChem (CID 170074390), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).